Sichuan Biokin Pharmaceutical Co Ltd - Class A

SHSE:688506 (China)   Class A
Â¥ 197.84 (+0.56%) Jun 19
18.07
P/B:
15.38
Market Cap:
Â¥ 79.33B ($ 10.93B)
Enterprise V:
Â¥ 73.82B ($ 10.17B)
Volume:
115.30M
Avg Vol (2M):
1.59M
Trade In:
Volume:
115.30M
Avg Vol (2M):
1.59M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Sichuan Biokin Pharmaceutical Co Ltd ( SHSE:688506 ) from 2023 to Jun 19 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Sichuan Biokin Pharmaceutical stock (SHSE:688506) PE ratio as of Jun 19 2024 is 18.07. More Details

Sichuan Biokin Pharmaceutical Co Ltd (SHSE:688506) PE Ratio (TTM) Chart

To

Sichuan Biokin Pharmaceutical Co Ltd (SHSE:688506) PE Ratio (TTM) Historical Data

Total 349
  • 1
  • 2
  • 3
  • 4
Sichuan Biokin Pharmaceutical PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-19 18.1 2024-04-11 11.7
2024-06-18 18.0 2024-04-10 11.6
2024-06-17 18.4 2024-04-09 11.8
2024-06-14 18.0 2024-04-08 11.5
2024-06-13 19.0 2024-04-03 11.3
2024-06-12 18.6 2024-04-02 10.9
2024-06-11 18.8 2024-04-01 11.1
2024-06-07 18.9 2024-03-29 11.5
2024-06-06 18.9 2024-03-28 11.4
2024-06-05 18.7 2024-03-27 At Loss
2024-06-04 17.6 2024-03-26 At Loss
2024-06-03 16.8 2024-03-25 At Loss
2024-05-31 16.1 2024-03-22 At Loss
2024-05-30 15.8 2024-03-21 At Loss
2024-05-29 16.1 2024-03-20 At Loss
2024-05-28 16.3 2024-03-19 At Loss
2024-05-27 16.4 2024-03-18 At Loss
2024-05-24 16.4 2024-03-15 At Loss
2024-05-23 16.6 2024-03-14 At Loss
2024-05-22 16.8 2024-03-13 At Loss
2024-05-21 16.9 2024-03-12 At Loss
2024-05-20 16.4 2024-03-11 At Loss
2024-05-17 17.5 2024-03-08 At Loss
2024-05-16 17.3 2024-03-07 At Loss
2024-05-15 17.7 2024-03-06 At Loss
2024-05-14 17.3 2024-03-05 At Loss
2024-05-13 17.0 2024-03-04 At Loss
2024-05-10 17.7 2024-03-01 At Loss
2024-05-09 16.7 2024-02-29 At Loss
2024-05-08 16.9 2024-02-28 At Loss
2024-05-07 15.9 2024-02-27 At Loss
2024-05-06 16.3 2024-02-26 At Loss
2024-04-30 14.1 2024-02-23 At Loss
2024-04-29 14.0 2024-02-22 At Loss
2024-04-26 13.2 2024-02-21 At Loss
2024-04-25 12.7 2024-02-20 At Loss
2024-04-24 12.3 2024-02-19 At Loss
2024-04-23 12.2 2024-02-08 At Loss
2024-04-22 11.2 2024-02-07 At Loss
2024-04-19 10.9 2024-02-06 At Loss
2024-04-18 10.9 2024-02-05 At Loss
2024-04-17 10.6 2024-02-02 At Loss
2024-04-16 10.9 2024-02-01 At Loss
2024-04-15 11.4 2024-01-31 At Loss
2024-04-12 11.9 2024-01-30 At Loss

Sichuan Biokin Pharmaceutical Co Ltd (SHSE:688506) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Sichuan Biokin Pharmaceutical Co Ltd is a chemical drug and biological drug-based company that integrates drug research and development, production and marketing.